Ad is loading...
EAPIF
Price
$3.95
Change
-$0.00 (-0.00%)
Updated
Aug 29 closing price
HLNCF
Price
$4.47
Change
+$0.05 (+1.13%)
Updated
Nov 15 closing price
Ad is loading...

EAPIF vs HLNCF

Header iconEAPIF vs HLNCF Comparison
Open Charts EAPIF vs HLNCFBanner chart's image
EUROAPI SA
Price$3.95
Change-$0.00 (-0.00%)
Volume$400
CapitalizationN/A
HALEON
Price$4.47
Change+$0.05 (+1.13%)
Volume$3.72K
CapitalizationN/A
EAPIF vs HLNCF Comparison Chart
Loading...
View a ticker or compare two or three
VS
EAPIF vs. HLNCF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EAPIF is a Hold and HLNCF is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (EAPIF: $3.95 vs. HLNCF: $4.47)
Brand notoriety: EAPIF and HLNCF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: EAPIF: 100% vs. HLNCF: 5%
Market capitalization -- EAPIF: $1.11B vs. HLNCF: $39.92B
EAPIF [@Pharmaceuticals: Other] is valued at $1.11B. HLNCF’s [@Pharmaceuticals: Other] market capitalization is $39.92B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EAPIF’s FA Score shows that 0 FA rating(s) are green whileHLNCF’s FA Score has 1 green FA rating(s).

  • EAPIF’s FA Score: 0 green, 5 red.
  • HLNCF’s FA Score: 1 green, 4 red.
According to our system of comparison, both EAPIF and HLNCF are a bad buy in the long-term.

Price Growth

EAPIF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while HLNCF (@Pharmaceuticals: Other) price change was -2.40% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.07%. For the same industry, the average monthly price growth was -7.87%, and the average quarterly price growth was -11.90%.

Industries' Descriptions

@Pharmaceuticals: Other (-5.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
HLNCF($39.9B) has a higher market cap than EAPIF($1.11B). EAPIF has higher P/E ratio than HLNCF: EAPIF (476.19) vs HLNCF (27.25). HLNCF YTD gains are higher at: 9.024 vs. EAPIF (-22.549). HLNCF has higher annual earnings (EBITDA): 2.06B vs. EAPIF (62.7M). HLNCF has higher revenues than EAPIF: HLNCF (11.2B) vs EAPIF (893M).
EAPIFHLNCFEAPIF / HLNCF
Capitalization1.11B39.9B3%
EBITDA62.7M2.06B3%
Gain YTD-22.5499.024-250%
P/E Ratio476.1927.251,748%
Revenue893M11.2B8%
Total CashN/A606M-
Total DebtN/A10.4B-
TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGASX28.920.31
+1.08%
Hennessy Gas Utility Institutional
VGENX51.870.37
+0.72%
Vanguard Energy Inv
SGHIX10.800.01
+0.09%
Sextant Global High Income
JEMZX9.13-0.06
-0.65%
JHancock Emerging Markets Equity C
GMCUX17.51-0.16
-0.91%
Goldman Sachs Small/Mid Cap Value R6

EAPIF and

Correlation & Price change

A.I.dvisor tells us that EAPIF and HLN have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EAPIF and HLN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EAPIF
1D Price
Change %
EAPIF100%
N/A
HLN - EAPIF
14%
Poorly correlated
+0.86%
HLNCF - EAPIF
11%
Poorly correlated
+1.13%
DHBUF - EAPIF
10%
Poorly correlated
+5.41%
IXHL - EAPIF
7%
Poorly correlated
-14.53%
STEK - EAPIF
6%
Poorly correlated
-4.47%
More

HLNCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLNCF has been loosely correlated with HLN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HLNCF jumps, then HLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLNCF
1D Price
Change %
HLNCF100%
+1.13%
HLN - HLNCF
49%
Loosely correlated
+0.86%
SGIOF - HLNCF
21%
Poorly correlated
+6.53%
STEK - HLNCF
11%
Poorly correlated
-4.47%
EAPIF - HLNCF
11%
Poorly correlated
N/A
ZTS - HLNCF
10%
Poorly correlated
+0.29%
More